A clinical trailto study the effects of two drugs, Pregabalin and Dulexetine in patients with neuropathic pain due to prolapsed intervertibral disc (PIVD)
Phase 4
- Conditions
- Health Condition 1: M512- Other thoracic, thoracolumbar andlumbosacral intervertebral disc displacement
- Registration Number
- CTRI/2021/06/034453
- Lead Sponsor
- Agartala government medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
18 years and above, all clinically diagnosed cases of neuropathic pain due to PIVD and who will be prescribed either Pregabalin or Duloxetine and fulfill the following criteria
a) Patients whose visual analogue scale >4.
b) Patients having DN4 questionnaires score >4.
c) Leeds assessment of neuropathic symptoms and sign (LANSS) >12
Exclusion Criteria
a) Neuropathic pain due to other co-morbidities e.g. (Peripheral Neuropathy, Alcoholic, Cancer).
b) Pregnancy and lactation.
c) Mental disorder.
d) Those who are receiving herbal medicine and homeopathy or any other medicine having pain modulator properties except NSAIDS.
e) Those who taken Pregabalin / Gabapentin or Duloxetine prior to the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method